Terawan Makes Nusantara Vaccine, PDI Party: Potential To Become A Game Changer

Former Health Minister Terawan Agus Putranto (Photo: Irfan Meidianto)

JAKARTA - It has been a long time since the former Health Minister Terawan Agus Putranto has been busy developing the Vaksin Nusantara (Vaccine) to fight COVID-19. This received appreciation from the Deputy Chairman of Commission IX of the DPR RI, Charles Honoris.

He even congratulated Terawan and his team on completing the first phase of clinical trials to develop the vaccine.

"We would like to convey our congratulations to Dr. Terawan and the Vaksin Nusantara research team who have completed the first phase of clinical trials. Of course, we appreciate it", Charles said in a written statement to reporters, Thursday, February 18.

He also assessed that this vaccine in the future has the potential to become a game-changer because it has different methods and technologies from existing vaccines. So it is hoped that, in the future, if it has passed further clinical trials and is ready for use, this vaccine can be used for people who have the comorbid disease.

"We appreciate their hard work and are at the same time proud of the discovery of the nation's children who have the potential to become a game-changer in terms of vaccination against Covid19. As has been widely reported, this Vaksin Nusantara uses different methods and technologies from vaccines that have been different", he said.

"Hopefully the Nusantara vaccine can pass the next stages of clinical trials well", added the PDI Party politician.

Previously reported, this Vaksin Nusantara has been developed by the former Head of the Gatot Subroto Army Hospital since he served as Minister of Health before being replaced by Budi Gunadi Sadikin.

Dr. Terawan said the results of the clinical trial of the Indonesian vaccine went well. In fact, the vaccine is claimed to be personal and can be used by all groups, including those with comorbidities.

"Of course, the generalized concept has to be changed to the concept of personality individual vaccination", said Terawan, quoted from Kompas TV, Wednesday, February 17.

In the process of making this Indonesian vaccine, said Terawan, it must go through an incubation process for approximately 7 days. Until later it will become an individual or personal vaccine.

"The point is that every time we have a dendritic cell, we only need to introduce the COVID-19 antigen so that it will have a dendritic cell memory against COVID-19", he said.

He also claims this vaccine will provide immunity for a long time. This is because this vaccine uses blood serum materials from each individual.